Toshihiro Nanki Selected Research

Toshihiro Nanki Research Topics

Disease

51	Rheumatoid Arthritis 08/2022 - 11/2002
14	Arthritis (Polyarthritis) 11/2021 - 01/2005
8	Inflammation (Inflammations) 01/2019 - 10/2005
8	Experimental Arthritis 05/2015 - 12/2004
6	Vasculitis (Vasculitides) 08/2022 - 02/2013
6	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 05/2009
6	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020 - 04/2011
6	Infections 12/2014 - 07/2011
5	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2021 - 06/2002
4	Glomerulonephritis 08/2022 - 12/2010
4	Atherosclerosis 11/2021 - 06/2005
4	Rheumatic Diseases (Rheumatism) 11/2020 - 01/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2019 - 05/2002
3	Osteoarthritis 12/2017 - 11/2002
3	Neoplasms (Cancer) 09/2016 - 06/2005
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 04/2020
2	COVID-19 12/2021 - 09/2020
2	Dermatomyositis (Dermatopolymyositis) 11/2020 - 03/2012
2	Lupus Nephritis 06/2019 - 01/2015
2	Nephritis 10/2018 - 12/2010
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2015 - 03/2012
2	Lung Diseases (Lung Disease) 11/2012 - 11/2012
2	Opportunistic Infections (Opportunistic Infection) 11/2012 - 11/2012
2	Experimental Nervous System Autoimmune Disease 10/2009 - 11/2005
1	Liver Failure 01/2022
1	Disease Progression 01/2022
1	Adult-Onset Still's Disease 01/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022
1	Cytokine Release Syndrome 12/2021

Drug/Important Bio-Agent (IBA)

10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 10/2005
10	CytokinesIBA 12/2021 - 11/2002
9	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 04/2011
9	Chemokine CX3CL1IBA 07/2021 - 12/2004
8	Biological ProductsIBA 08/2022 - 11/2012
8	Abatacept (Orencia)FDA Link 08/2022 - 09/2016
8	GlucocorticoidsIBA 12/2021 - 07/2014
8	Prednisolone (Predate)FDA LinkGeneric 07/2021 - 06/2002
8	ChemokinesIBA 05/2021 - 01/2005
7	Antirheumatic Agents (DMARD)IBA 08/2022 - 07/2011
7	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 01/2009
6	Etanercept (Enbrel)FDA Link 09/2016 - 12/2010
5	tocilizumab (atlizumab)FDA Link 12/2021 - 11/2012
5	Monoclonal AntibodiesIBA 07/2021 - 10/2005
5	LigandsIBA 05/2021 - 11/2002
4	Tacrolimus (Prograf)FDA LinkGeneric 12/2021 - 08/2011
4	AntibodiesIBA 11/2021 - 09/2009
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2012
4	RetinoidsIBA 01/2015 - 10/2009
4	tamibaroteneIBA 01/2015 - 10/2009
3	Infliximab (Remicade)FDA Link 12/2021 - 11/2012
3	AutoantibodiesIBA 11/2021 - 01/2009
3	quetmolimabIBA 07/2021 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2019 - 01/2008
3	Lysophosphatidic Acid ReceptorsIBA 01/2019 - 08/2013
3	lysophosphatidic acidIBA 01/2019 - 08/2013
3	Adalimumab (Humira)FDA Link 09/2016 - 11/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2016 - 10/2014
3	Messenger RNA (mRNA)IBA 10/2014 - 05/2002
3	Therapeutic UsesIBA 08/2014 - 01/2005
2	Peroxidase (Myeloperoxidase)IBA 08/2022 - 07/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 07/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2014
2	tofacitinibIBA 12/2021 - 01/2021
2	Janus Kinase InhibitorsIBA 12/2021 - 01/2018
2	InterleukinsIBA 12/2021 - 06/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2021 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 05/2015
2	Immunoglobulin G (IgG)IBA 01/2021 - 08/2014
2	Trimethoprim (Proloprim)FDA LinkGeneric 01/2020 - 01/2017
2	Thymidine Monophosphate (TMP)IBA 01/2020 - 01/2017
2	Sulfamethoxazole FDA LinkGeneric 01/2020 - 01/2017
2	LipidsIBA 01/2019 - 08/2013
2	AdipokinesIBA 12/2017 - 09/2016
2	ResistinIBA 12/2017 - 09/2016
2	C-Reactive ProteinIBA 05/2015 - 06/2013
2	EnzymesIBA 10/2014 - 06/2002
2	Collagen Type II (Type II Collagen)IBA 08/2014 - 08/2013
2	Rituximab (Mabthera)FDA Link 07/2014 - 04/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2014 - 01/2008
2	Interleukin-17 (Interleukin 17)IBA 06/2010 - 10/2009
2	Interferon-gamma (Interferon, gamma)IBA 10/2009 - 10/2005
2	Myosins (Myosin)IBA 10/2009 - 11/2005
2	NF-kappa B (NF-kB)IBA 01/2007 - 01/2005
1	Certolizumab Pegol FDA Link 07/2022
1	SteroidsIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Colchicine FDA LinkGeneric 12/2021
1	Chloroquine (Aralen)FDA LinkGeneric 12/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2021
1	canakinumab FDA Link 12/2021
1	sarilumabIBA 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	baricitinibIBA 12/2021
1	apremilastIBA 12/2021
1	siltuximabIBA 12/2021

Therapy/Procedure

21	Therapeutics 07/2021 - 06/2002
3	Biological Therapy 01/2022 - 11/2012
2	Intraperitoneal Injections 04/2017 - 02/2013
1	Critical Care (Surgical Intensive Care) 01/2022
1	Liver Transplantation 01/2022